Avelumab for People With Recurrent Respiratory Papillomatosis

NCT02859454 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

NIH

Sponsor class

Conditions

Recurrent Respiratory Papillomatosis
Juvenile Laryngeal Papilloma
Laryngeal Papilloma, Recurrent
Respiratory Papillomatosis
Human Papilloma Virus

Interventions

DRUG: Avelumab

Sponsor

National Cancer Institute (NCI)